Rebion

https://www.newswire.com/news/rebion-awarded-1-0m-by-the-nih-to-study-longitudinal-monitoring-of-21678000

Rebion Awarded $1.0M by the NIH to Study Longitudinal Monitoring of TBI in Athletes The National Institute of Neurological Disorders and Stroke has awarded Rebion a two-year, $1.0M SBIR grant to research traumatic brain injury monitoring

David G. Hunter, MD, PhD Ophthalmologist-in-Chief at Boston Children's Hospital delivers an inspiring lecture that brought the audience on his career-long journey to develop and commercialize the blinq.® vision scanner. Direct detection of amblyopia and strabismus is now possible with the blinq.® vision scanner.

Congrats David!

NIH-funded study shows screening device accurately detects amblyopia (lazy eye)

http://ow.ly/HVjz50GhB93

Rebion's Neural Performance Scanning technology powers the blinq.® device for early identification of amblyopia (lazy eye) at Tampa Lions' Vision Health Program screenings.